Transl Psychiatry
KetamineRandomized Controlled Trials as TopicStereoisomerism
Dr. Michael Frederic Grunebaum, MD
NPI1053439687
- Part D claims, 2024
- 388
- Publications
- 61
- Clinical trials
- 3
- Industry payments
- $361
- State license
- 1
- Practice address
- 630 W 168th St, New York, NY 10032
- Practice phone
- Call (212) 580-4252
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Grunebaum's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michael Frederic Grunebaum is a psychiatrist in New York, New York
Dr. Grunebaum practices in New York, New York.
Dr. Grunebaum's NPI, 1053439687, was assigned on March 26, 2007. Dr. Grunebaum graduated from Harvard Medical School in 1991. Dr. Grunebaum holds New York license 190740.
NPI and contact details
- NPI
- 1053439687NPI Registry (opens in a new tab)
- NPI enumeration date
- March 26, 2007
- NPI status
- Active
- Practice phone
- (212) 580-4252
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 1991
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Michael Frederic Grunebaum's practice address is in New York, New York
Dr. Grunebaum's practice address in the NPI Registry is 630 W 168th St, New York, NY 10032, in New York County. The practice phone is (212) 580-4252.
- NPI Registry address630 W 168th St, New York, NY 10032 · New York CountyPhone(212) 580-4252
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Michael Frederic Grunebaum's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grunebaum practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Grunebaum's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Grunebaum practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michael Frederic Grunebaum is one of 4,448 psychiatrists in New York
Psychiatry is Dr. Grunebaum's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Grunebaum is licensed in New York.
Specialties and state licenses
- Psychiatry, New YorkPrimary
Psychiatrists near Dr. Grunebaum
Counts of psychiatrists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michael Frederic Grunebaum's patients have a median age of 32
Across all payers, Dmand AI patient panel data puts Dr. Grunebaum's median patient age at 32, with 71% women.
Dr. Grunebaum's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 32
Patient panel by sex, all payers
- Women71%
- Men14%
Source: Dmand AI Patient Panel Data
Dr. Michael Frederic Grunebaum wrote 388 Medicare Part D claims in 2024
In 2024, Dr. Grunebaum wrote 388 Medicare Part D claims for 26 patients. 96% of them were for generic drugs. CMS names the drug for 265 of them, across 14 drugs with 11 or more claims each, at $4,892 in total drug cost. In 2023, CMS named 246 claims across 14 drugs.
Part D claims, 2024388
Drugs named by CMS14
Total drug cost$4,892
Part D patients26
Dr. Grunebaum's Part D claims by kind of drug, 2024
- Generic372 claims96%
- Brand-name16 claims4%
Dr. Grunebaum's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Grunebaum's Part D claims, 2024
- Antipsychotics, patients 65 and over6%25 of 388 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2462024: 2658%
Drugs named by CMS: 14 in 2024, 14 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Find psychiatrists like Dr. Grunebaum by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Michael Frederic Grunebaum has 61 publications on record
Dmand AI links 61 papers to Dr. Grunebaum, published from 2009 to 2025. 2017 was the busiest year, with 6. The most frequent topics are Depressive Disorder, Major, Suicide, Attempted and Suicidal Ideation. Dr. Grunebaum has published most often in J Affect Disord. Dr. Grunebaum's most frequent co-authors are Joseph John Mann, MD, Leo Sher, MD and Steven Paul Ellis, MD.
Papers61
Years published2009 to 2025
Dr. Grunebaum's papers by year, 2014 to 2025
Topics Dr. Grunebaum writes about most
- Depressive Disorder, Major
- Suicide, Attempted
- Suicidal Ideation
- Bipolar Disorder
- Ketamine
- Psychiatric Status Rating Scales
- Antidepressive Agents
- Double-Blind Method
Dr. Grunebaum's most frequent co-authors
Recent publications by Dr. Grunebaum
J Affect Disord
Bipolar DisorderLithiumSuicidal Ideation
Psychiatry Res
Antidepressive AgentsBlack or African AmericanDepressive Disorder, Major
J Affect Disord
Father-Child RelationsMental HealthMood Disorders
See who Dr. Grunebaum researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Grunebaum works with, so you can find a warm path to the right psychiatrists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michael Frederic Grunebaum has worked on 3 clinical trials
Dmand AI links Dr. Grunebaum to 3 clinical trials, 2 of them phase 4 studies. Conditions studied include Suicidal Ideation and Suicide. New York State Psychiatric Institute sponsors the most, 3.
Clinical trials with Dr. Grunebaum by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- NonePhase 2: no trials
- NonePhase 3: no trials
- 2Phase 4: 2 trials
Conditions in Dr. Grunebaum's trials
- Suicidal Ideation
- Suicide
Recent clinical trials with Dr. Grunebaum
Suicidal IdeationSuicideKetamine hydrochloride injectionMidazolam injection
Ketamine vs. Midazolam in Bipolar Depression (opens in a new tab)
CompletedPhase 1/2
Suicidal IdeationSuicideKetamineMidazolam
Ketamine vs. Midazolam: Testing Rapid Relief of Suicide Risk in Depression (opens in a new tab)
CompletedPhase 4
Suicidal IdeationSuicideKetamineMidazolam
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Michael Frederic Grunebaum received $361 in industry payments from 2018 to 2023
CMS Open Payments shows 6 general payments to Dr. Grunebaum from 2 drug and device companies from 2018 to 2023. Travel and lodging make up the largest share, 52% of the total. Janssen Research & Development, LLC paid the most, $318.
General payments to Dr. Grunebaum by program year, 2018 to 2023
General payments to Dr. Grunebaum by kind, 2018 to 2023
$361in total
- Travel and lodging$18852%
- Food and beverage$13036%
- Education$4312%
Companies that paid Dr. Grunebaum the most, 2018 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Michael Frederic Grunebaum graduated from Harvard Medical School
Dr. Grunebaum graduated from Harvard Medical School in 1991.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Michael Frederic Grunebaum's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michael Frederic Grunebaum
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michael Frederic Grunebaum's NPI number?
Dr. Michael Frederic Grunebaum's NPI number is 1053439687. It was assigned on March 26, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Michael Frederic Grunebaum?
Dr. Michael Frederic Grunebaum is a psychiatrist in New York, New York. The primary specialty in the NPI Registry is Psychiatry Physician (taxonomy code 2084P0800X).
Where does Dr. Michael Frederic Grunebaum practice?
Dr. Grunebaum practices at 630 W 168th St, New York, NY 10032.
What is Dr. Michael Frederic Grunebaum's office phone number?
The practice phone on file for Dr. Grunebaum is (212) 580-4252.
What is Dr. Michael Frederic Grunebaum's medical license number?
Dr. Grunebaum holds New York license 190740.
Where did Dr. Michael Frederic Grunebaum go to medical school?
Dr. Grunebaum graduated from Harvard Medical School in 1991.
What drugs does Dr. Michael Frederic Grunebaum prescribe most?
In 2024 Medicare Part D data, Dr. Grunebaum's most prescribed drugs by claims were Sertraline HCl, Duloxetine HCl and Quetiapine Fumarate.
Has Dr. Michael Frederic Grunebaum received payments from drug or device companies?
CMS Open Payments shows $361 in general payments to Dr. Grunebaum from 2 companies from 2018 to 2023. The largest total came from Janssen Research & Development, LLC.
How long has Dr. Michael Frederic Grunebaum been practicing?
Dr. Grunebaum graduated from medical school in 1991, 35 years ago.
Does Dr. Michael Frederic Grunebaum do research?
Dmand AI links 61 publications to Dr. Grunebaum, published from 2009 to 2025. Dr. Grunebaum has worked on 3 clinical trials.
Who does Dr. Michael Frederic Grunebaum publish with?
Dr. Grunebaum's most frequent co-authors are Joseph John Mann, MD (23 shared papers), Leo Sher, MD (8 shared papers) and Steven Paul Ellis, MD (5 shared papers).
Selling to psychiatry practices?
See psychiatrists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card